Abstract
The effects of the patented treated-yeast, Saccharomyces cerevisiae, a probiotic suspension which was shown earlier to present neuroprotective and neurorestorative properties, upon allergies presented by a group (n=8) of patients, that were compared with a matched group of patients administered untreated yeast cells (n=8). Treated yeast cells were subjected to millimeter-wave exposure as outlined in patented documents. The patients who administered themselves treated Milmed, over periods extending from four-to-thirteen weeks, completed subjective self-report ratings of their allergy symptoms that indicated marked ameliorative effects; additionally, they rated their general health situations to be markedly improved. Those patients who had taken the untreated yeast did not report these improvements. Correlational analyses between the number of weeks treated Milmed was taken by patients and (i) alleviation of allergy symptoms, and (ii) improvement in general health status, indicated significant relationships in each case. The significant correlations between symptom improvements and general health status, on one hand, and the number of weeks treated Milmed was ingested imply that complete treatments are required for the optimal therapeutic benefits. As observed previously, 8-to-13-week episodes of treated Milmed self-administration provides a lasting amelioration from allergy symptoms and an improved general health status.
Highlights
Introduction overwhelming increases generally to theA large proportion of individuals are sufferers from allergic rhinitis and related allergies among the Western and the industrialised countries
The present study presents a follow-up to the 1st study on the effects of treatment with yeast cells according to the patent application upon ongoing allergy symptoms among sufferers
Have you experienced any improvement due to the treatment associated with the alleviation of your allergy symptoms? Scale 1 to 10 (1=no improvement; 10=symptom free)
Summary
Introduction overwhelming increases generally to theA large proportion of individuals (up to and above 20% of adults) are sufferers from allergic rhinitis and related allergies among the Western and the industrialised countries. These ‘allergens’, due to their allergy-inducing properties, may involve ‘aero-allergens’, such as dust mite, mold, tree weed and grass pollen, and ‘foodallergens’, such as peanuts, milk, egg, soy, wheat, nut and/or fish proteins [3,4,5]. These allergy symptoms encompass reddening of the eyes, persistent itchy rashes, nasal itchiness, reactions within the roof of the mouth, throat, eyes, sneezing, a stuffy nose (presenting nasal congestion), and runny noses, tears running from the eyes, a shortness of breath, or swelling.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
